Latest Posts
About This Stock
More About This Stock
Read
Read
Read
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Article By:
Benzinga
Saturday, July 10, 2021 3:54 PM EDT
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the coming months.
Morning Call For Wednesday, Jan 24
Article By:
Jim Van Meerten
Wednesday, January 24, 2018 9:42 AM EDT
Mar E-mini S&Ps (ESH18 +0.20%) this morning are up +0.13% at a new record nearest-futures high after U.S. Treasury Secretary Mnuchin endorsed a plunge in the dollar index to a 3-year low.
In this article: COF, MCK, TK, TSS, TXN, UAL, BOLD, ARAY, CERS, MRCY, QGEN, SIRI, PBYI, FPRX, AERI, RCKT
Premarket Biotech Digest – RDUS Reports Positive Results, RHHBY Investigates Case, QDEL Receives Japanese Approval
Article By:
KKD Healthcare Analytics
Thursday, May 25, 2017 9:50 AM EDT
Aerie Pharmaceuticals announced positive results from its Phase 3 clinical trial, Mercury 2. Puma Biotechnology is reprorted to have received 12-4 approval from an FDA advisory committee for its experimental breast cancer drug.